Deals
Imprimis Pharmaceuticals Raises $10M at 12% Discount
|
Imprimis Pharmaceuticals (NASDAQ CM:IMMY) announced that it has raised $10,440,000 in a CMPO/Overnight transaction.
Growth Capitalist (https://growthcapitalist.com/category/premium-articles/page/56/)
Growth capital news and research from Growth Capital Investor, the journal of emerging growth company finance. Subscription required.
Imprimis Pharmaceuticals (NASDAQ CM:IMMY) announced that it has raised $10,440,000 in a CMPO/Overnight transaction.
Liquidmetal Technologies (OTC:LQMT) announced that it has raised $30,000,000 in a Common Stock transaction.
Jensyn Acquisition Corporation (NASDAQ CM:JSYNU) announced that it has raised $2,945,000 in a Units (Common Stock + Warrants) transaction.
Solazyme (NASDAQ GS:SZYM) announced that it has raised $27,850,000 in a Convertible Preferred Stock transaction.